Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results

Fig. 6

Increase in “vertical ellipsoid zone width” according to study timepoints (T0, T1, T2) in the eye treated with the WJ-MSCs (Table 1, patient 24: left eye—the points where the ellipsoid zone intersects the outer limiting membrane are marked as EZ length reference points, as indicated by the arrows). a Before application, 3.21 mm. b At 6th month, 3.34 mm. c At 12th month, 3.35 mm

Back to article page